DNTH - Dianthus Therapeutics, Inc. /DE/

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 23.81

Open

$ 24.16

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 23.46 - $ 24.16

52 Week Range

$ 0.61 - $ 33.77

Volume

88,314

Average Volume

Market Cap

122.7M

Beta (5Y Monthly)

$ 1.28

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-21-2024	12-31-2023	10-K
2	11-09-2023	09-30-2023	10-Q
3	08-03-2023	06-30-2023	10-Q
4	05-15-2023	03-31-2023	10-Q
5	03-23-2023	12-31-2022	10-K
6	11-03-2022	09-30-2022	10-Q
7	08-04-2022	06-30-2022	10-Q
8	05-16-2022	03-31-2022	10-Q
9	03-08-2022	12-31-2021	10-K
10	11-04-2021	09-30-2021	10-Q
11	08-05-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	03-03-2021	12-31-2020	10-K
14	11-05-2020	09-30-2020	10-Q
15	08-06-2020	06-30-2020	10-Q
16	05-07-2020	03-31-2020	10-Q
17	03-03-2020	12-31-2019	10-K
18	11-13-2019	09-30-2019	10-Q
19	08-08-2019	06-30-2019	10-Q
20	05-09-2019	03-31-2019	10-Q
21	03-19-2019	12-31-2018	10-K
22	11-08-2018	09-30-2018	10-Q
23	08-09-2018	06-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

What 5 Analyst Ratings Have To Say About D...
04/18/2024 18:01:31

Raymond James Maintains Outperform on Dian...
04/18/2024 17:05:58

Raymond James analyst Steven Seedhouse maintains Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform and raises the price ...

why-cutera-shares-are-trading-lower-by-over-26-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Cutera Shares Are Trading Lower By Ove...
03/22/2024 18:39:16

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...

worthington-steel-posts-upbeat-results-joins-summit-midstream-partners-fedex-and-other-big-stocks-moving-higher-on-friday

Worthington Steel Posts Upbeat Results, Jo...
03/22/2024 14:08:47

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

Wedbush Maintains Outperform on Dianthus T...
03/22/2024 14:03:06

Wedbush analyst Laura Chico maintains Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform and raises the price target from...

Dianthus Therapeutics Q4 EPS $(0.71) Beats...
03/21/2024 20:03:52

Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of...

Dianthus Therapeutics Has Initiated Phase ...
02/26/2024 12:04:28

Decoding 4 Analyst Evaluations For Dianthu...
02/15/2024 12:00:51

Stifel Initiates Coverage On Dianthus Ther...
02/15/2024 11:12:55

Stifel analyst Alex Thompson initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Buy rating and announces Price...

Avidity Partners Management LP Reported 9....
01/31/2024 17:26:19

Wedbush Maintains Outperform on Dianthus T...
01/26/2024 13:38:32

Wedbush analyst Laura Chico maintains Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform and raises the price target from...

why-dianthus-therapeutics-dnth-stock-is-exploding-higher

Why Dianthus Therapeutics (DNTH) Stock Is ...
01/22/2024 21:18:47

Dianthus Therapeutics shares traded higher by 37% Monday. The company announced a $230 million private placement.

Dianthus Therapeutics Enters Agreement For...
01/22/2024 12:43:23

Pursuant to the terms of the securities purchase agreement, Dianthus is selling an aggregate of 14,500,500 shares of its common...

Jefferies Initiates Coverage On Dianthus T...
12/26/2023 12:40:41

Jefferies analyst Maury Raycroft initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Buy rating and announces P...

antibody-player-dianthus-therapeutics-has-potential-amid-active-ma-landscape-in-complement-focused-firms-analyst

Antibody Player Dianthus Therapeutics Has ...
11/22/2023 18:12:41

Wedbush initiated coverage on Dianthus Therapeutics Inc (NASDAQ: DNTH), noting its lead program DNTH103 as a well-positioned mo...

Wedbush Initiates Coverage On Dianthus The...
11/22/2023 12:24:50

Wedbush analyst Laura Chico initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform rating and announces...

Dianthus Therapeutics Q3 EPS $(3.78), Sale...
11/09/2023 22:37:13

Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(3.78) per share. The company reported quarterly sales of $9...

dianthus-monoclonal-antibody-on-promising-pathway-to-gaining-the-upper-hand---analyst

Dianthus' Monoclonal Antibody On Promising...
09/28/2023 19:33:57

Raymond James initiated coverage on Dianthus Therapeutics Inc (NASDAQ: DNTH), a recent reverse merger with the old Magenta Ther...

Benzinga's Top Ratings Upgrades, Downgrade...
09/28/2023 15:00:45

Raymond James Initiates Coverage On Dianth...
09/28/2023 13:14:36

Raymond James analyst Steven Seedhouse initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform rating an...